HOME Top Market Reports Bioabsorbable Stents Market by Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Global Forecast to 2021

Bioabsorbable Stents Market by Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: June 2016
Report Code: MD 4383

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.

Europe commanded the largest share of the global bioabsorbable stents market in 2016, followed by North America. Europe commanded the largest share of the global market in 2016 and is expected to grow at the highest CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.

The bioabsorbable stents market is dominated by few players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Reva Medical, Inc. (U.S.), Arterial Remodeling Technologies (France), Kyoto Medical Planning. Co. Ltd. (Japan).

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This report covers the global bioabsorbable stents market by material, absorption rate, drugs application, end user, and region.

Bioabsorbable Stents Market, by Material

  •  Polymeric Stents
  •  Metallic Stents

Bioabsorbable Stents Market, by Absorption Rate

  • Fast Absorption
  • Slow Absorption

Bioabsorbable Stents Market, by Drug

  • Limus-based Drugs
  • Paclitaxel Drugs

Bioabsorbable Stents Market, by Application

  • Coronary Artery Disease
  • Peripheral Artery Disease

Bioabsorbable Stents Market, by End User

  • Hospital
  • Cardiac Centers

Bioabsorbable Stents Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe (RoE)
  • Asia
    • Japan
    • China
    • India
    • Rest of Asia (RoA)
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs.

The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to 5)

Further Split of the Bioabsorbable Stents Market

Bioabsorbable stents market size and growth rate estimates for Australia, New-Zealand, Singapore

Further Split of the RoW Bioabsorbable Stents Market

Bioabsorbable Stents market size and growth rate estimates for Latin America, the Middle East, and Africa

Table of Contents

1 Introduction (Page No. - 13)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Market Stakeholders

2 Research Methodology (Page No. - 16)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
    2.3 Key Data From Secondary Sources
    2.4 Key Data From Primary Sources
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 23)

4 Premium Insights (Page No. - 28)
    4.1 Bioabsorbable Stents Market, By Material
    4.2 Bioabsorbable Stents Market, By Absorption Rate
    4.3 Bioabsorbable Stents Market, By End User
    4.4 Bioabsorbable Stents Market, By Region

5 Market Overview (Page No. - 31)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Rapidly Growing Aging Population and Increased Risk of Coronary Artery Disease and Peripheral Artery Disease in the Elderly
                    5.2.1.2 Strong Product Pipeline
           5.2.2 Restraints
                    5.2.2.1 High Device Costs
           5.2.3 Opportunities
                    5.2.3.1 Emerging Markets to Offer High-Growth Opportunities for Market Players
           5.2.4 Challenges
                    5.2.4.1 Presence of Substitutes
                    5.2.4.2 High Risk of Complications

6 Regulatory Scenario (Page No. - 37)
    6.1 Introduction
    6.2 FDA and CE Approvals
    6.3 PMA Approvals and Government Certificates

7 Bioabsorbable Stents Market, Pipeline Products (Page No. - 39)
    7.1 Introduction
    7.2 Patents

8 Bioabsorbable Stents Market, By Material (Page No. - 41)
    8.1 Introduction
    8.2 Polymeric Stents
    8.3 Metallic Stents

9 Bioabsorbable Stents Market, By Absorption Rate (Page No. - 46)
    9.1 Introduction
    9.2 Slow-Absorption Stents
    9.3 Fast-Absorption Stents

10 Bioabsorbable Stents Market, By Drug (Page No. - 51)
     10.1 Introduction
     10.2 Paclitaxel
     10.3 Limus-Based Drugs

11 Bioabsorbable Stents Market, By Application (Page No. - 55)
     11.1 Introduction
     11.2 Coronary Artery Disease
     11.3 Peripheral Artery Disease

12 Bioabsorbable Stents Market, By End User (Page No. - 60)
     12.1 Introduction
     12.2 Hospitals
     12.3 Cardiac Centers

13 Bioabsorbable Stents Market, By Region (Page No. - 65)
     13.1 Introduction
     13.2 North America
             13.2.1 U.S.
             13.2.2 Canada
     13.3 Europe
             13.3.1 Germany
             13.3.2 France
             13.3.3 U.K.
             13.3.4 Rest of Europe (RoE)
     13.4 Asia
             13.4.1 Japan
             13.4.2 China
             13.4.3 India
             13.4.4 Rest of Asia
     13.5 Rest of the World

14 Competitive Landscape (Page No. - 98)
     14.1 Overview
     14.2 Market Share Analysis
     14.3 Competitive Situations & Trends
             14.3.1 New Product Launches & Product Approvals
             14.3.2 Agreements
             14.3.3 Investments

15 Company Profiles (Page No. - 103)
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
     15.1 Introduction
     15.2 Abbott Laboratories
     15.3 Reva Medical, Inc.
     15.4 Elixir Medical Corporation
     15.5 Kyoto Medical Planning Co., Ltd.
     15.6 Amaranth Medical, Inc.
     15.7 Arterial Remodeling Technologies
     15.8 Biotronik
     15.9 Xenogenics Corporation (A Subsidiary of Multicell Technologies, Inc.)
     15.10 Meril Life Sciences
     15.11 SMT (Part of Sahajanand Group of Companies)
     15.12 Tepha, Inc.
     15.13 Arterius Limited

*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.

16 Appendix (Page No. - 117)
     16.1 Insights From Industry Experts
     16.2 Discussion Guide
     16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     16.4 Introducing RT: Real-Time Market Intelligence
     16.5 Available Customizations
     16.6 Related Reports


List of Tables (88 Tables)

Table 1 Growing Aging Population is Driving Market Growth
Table 2 Cost Comparison Among Different Types of Stents
Table 3 High Device Costs are Restraining Market Growth
Table 4 Emerging Markets Offer High-Growth Opportunities for Market Players
Table 5 List of the Approved Products
Table 6 Pipeline Products
Table 7 Patented Bioabsorbable Stents
Table 8 Patented Products
Table 9 Bioabsorbable Stents Market Size, By Material, 2014–2021 (USD Million)
Table 10 Polymeric Stents Market Size, By Region, 2014–2021 (USD Million)
Table 11 Metallic Stents Market Size, By Region, 2017–2021 (USD Million)
Table 12 Bioabsorbable Stents Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 13 Slow-Absorption Stents Market Size, By Region, 2014-2021 (USD Million)
Table 14 Fast-Absorption Stents Market Size, By Region, 2014-2021 (USD Million)
Table 15 Market Size, By Drug, 2014–2021 (USD Million)
Table 16 Paclitaxel Market Size, By Region, 2014-2021 (USD Million)
Table 17 Limus-Based Drugs Market Size, By Region, 2014-2021 (USD Million)
Table 18 Market Size, By Application, 2014–2021 (USD Million)
Table 19 Market Size for Coronary Artery Disease, By Region, 2014–2021 (USD Million)
Table 20 Market Size for Peripheral Artery Disease, By Region, 2014–2021 (USD Million)
Table 21 North America Market Size for Peripheral Artery Disease, By Region, 2017–2021 (USD Million)
Table 22 Market Size, By End User, 2014-2021 (USD Million)
Table 23 Hospitals Market Size, By Region, 2014-2021 (USD Million)
Table 24 North America Hospitals Market Size, By Region, 2017-2021 (USD Million)
Table 25 Cardiac Centers Market Size, By Region, 2014-2021 (USD Million)
Table 26 Market Size, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size, By Country, 2017–2021 (USD Million)
Table 28 North America: Market Size, By Material, 2017–2021 (USD Million)
Table 29 North America: Market Size, By Absorption Rate, 2017–2021 (USD Million)
Table 30 North America: Market Size, By Application, 2017–2021 (USD Million)
Table 31 North America: Market Size, By End User, 2017–2021 (USD Million)
Table 32 U.S.: Market Size, By Material, 2017–2021 (USD Million)
Table 33 U.S.: Market Size, By Absorption Rate, 2017–2021 (USD Million)
Table 34 U.S.: Market Size, By Application, 2017–2021 (USD Million)
Table 35 U.S.: Market Size, By End User , 2017–2021 (USD Million)
Table 36 Canada: Market Size, By Material, 2017–2021(USD Million)
Table 37 Canada: Market Size, By Absorption Rate, 2017–2021 (USD Million)
Table 38 Canada: Market Size, By Type, 2017–2021 (USD Million)
Table 39 Canada: Market Size, By End User, 2017–2021 (USD Million)
Table 40 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Market Size, By Material, 2014–2021 (USD Million)
Table 42 Europe: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 43 Europe: Market Size, By Application, 2014–2021 (USD Million)
Table 44 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 45 Germany: Market Size, By Material, 2014–2021 (USD Million)
Table 46 Germany: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 47 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 48 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 49 France: Market Size, By Material, 2014–2021 (USD Million)
Table 50 France: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 51 France: Market Size, By Application, 2014–2021 (USD Million)
Table 52 France: Market Size, By End User, 2014–2021 (USD Million)
Table 53 U.K.: Market Size, By Material, 2014–2021 (USD Million)
Table 54 U.K.: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 55 U.K.: Market Size, By Application, 2014–2021 (USD Million)
Table 56 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 57 RoE: Market Size, By Material, 2014–2021 (USD Million)
Table 58 RoE: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 59 RoE: Market Size, By Application, 2014–2021 (USD Million)
Table 60 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Asia: Market Size, By Country, 2014–2021 (USD Million)
Table 62 Asia: Market Size, By Material, 2014–2021 (USD Million)
Table 63 Asia: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 64 Asia: Market Size, By Application, 2014–2021 (USD Million)
Table 65 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 66 Japan: Market Size, By Material, 2014–2021 (USD Million)
Table 67 Japan: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 68 Japan: Market Size, By Application, 2014–2021 (USD Million)
Table 69 Japan: Market Size, By End User, 2014–2021 (USD Million)
Table 70 China: Market Size, By Material, 2014–2021 (USD Million)
Table 71 China: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 72 China: Market Size, By Application, 2014–2021 (USD Million)
Table 73 China: Market Size, By End User, 2014–2021 (USD Million)
Table 74 India: Market Size, By Material, 2014–2021 (USD Million)
Table 75 India: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 76 India: Market Size, By Application, 2014–2021 (USD Million)
Table 77 India: Market Size, By End User, 2014–2021 (USD Million)
Table 78 RoA: Market Size, By Material, 2014–2021 (USD Million)
Table 79 RoA: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 80 RoA: Market Size, By Application, 2014–2021 (USD Million)
Table 81 RoA: Market Size, By End User, 2014–2021 (USD Million)
Table 82 RoW: Market Size, By Material, 2014–2021 (USD Million)
Table 83 RoW: Market Size, By Absorption Rate, 2014–2021 (USD Million)
Table 84 RoW: Market Size, By Application, 2014–2021 (USD Million)
Table 85 RoW: Market Size, By End User, 2014–2021 (USD Million)
Table 86 New Product Launches & Product Approvals, 2014–2016
Table 87 Agreements, 2014–2016
Table 88 Investments, 2014–2016


List of Figures (43 Figures)

Figure 1 Bioasorbable Stents Market
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Polymeric Stents to Witness Highest Growth During the Forecast Period
Figure 8 Bioabsorbable Stents Market, By Absorption Rate (2016 vs 2021)
Figure 9 Limus-Based Drugs to Grow at the Highest CAGR During the Forecast Period
Figure 10 Coronary Artery Disease, the Fastest-Growing Application Segment
Figure 11 Bioabsorbable Stents Market, By End User: Hospitals to Offer Significant Growth Opportunities During the Forecast Period
Figure 12 Bioabsorbable Stents Market, By Region: North America is Expected to Witness the Highest Growth During the Forecast Period
Figure 13 Polymer-Based Bioabsorbable Stents Market to Grow at the Highest CAGR From 2016 to 2021
Figure 14 Slow Absorbable Stents to Dominate the Market in 2016
Figure 15 Hospitals Segment to Command the Largest Market Share During the Forecast Period
Figure 16 North America to Witness Highest Growth During the Forecast Period
Figure 17 Bioabsorbable Stents Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Prevalence of Coronary Artery Disease, By Age & Sex (2009–2012)
Figure 19 Metallic Bioabsorbable Stents Market Size, 2017–2021 (USD Million)
Figure 20 North America Polymeric Stents Market Size, 2017–2021 (USD Million)
Figure 21 Bioabsorbable Stents Market, By Absorption Rate, 2014–2021 (USD Million)
Figure 22 Slow-Absorption Stents to Hold the Largest Share of the Market in 2016
Figure 23 North America Slow- Absorption Stents Market Size, 2017–2021 (USD Million)
Figure 24 North America Fast-Absorption Rate Stents Market Size, By Region, 2017-2021 (USD Million)
Figure 25 North America Paclitaxel Market Size, By Region, 2017-2021 (USD Million)
Figure 26 North America Limus-Based Drugs Market Size, By Region, 2017-2021 (USD Million)
Figure 27 The Coronary Artery Disease Application Segment to Dominate the Bioabsorbable Stents Market During the Forecast Period
Figure 28 North America Bioabsorbable Stents Market Size for Coronary Artery Disease, 2017–2021 (USD Million)
Figure 29 Bioabsorbable Stents Market Segmentation, By End User
Figure 30 North America Cardiac Centers Market Size, 2017-2021 (USD Million)
Figure 31 North America Bioabsorbable Stents Market Size (2017-2021)
Figure 32 U.S. to Hold the Largest Share of the Global Bioabsorbable Stents Market
Figure 33 European Bioabsorbable Stents Market Snapshot
Figure 34 Asian Bioabsorbable Stents Market Snapshot (2016)
Figure 35 RoW Bioabsorbable Stents Market Snapshot, 2016
Figure 36 New Product Launches & Product Approvals Was the Key Growth Strategy Adopted By Players in the Bioabsorbable Stents Market
Figure 37 Bioabsorbable Stents Market Share, By Key Player (2015)
Figure 38 Market Evolution Framework: New Product Launches are Fueling Market Growth
Figure 39 Battle for Market Share: New Product Launches & Product Approvals is the Key Growth Strategy Adopted By Leading Market Players
Figure 40 Product Benchmarking for the Top 4 Players
Figure 41 Abbott Laboratories: Company Snapshot
Figure 42 Reva Medical, Inc.: Company Snapshot
Figure 43 Multicell Technologies, Inc.: Company Snapshot

The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.

Based on material, the market is segmented into polymer stents, and metallic stents. The polymeric stents segment is expected to grow at the highest CAGR. This is attributed to the various facts such as polymer-based bioabsorbable stents comprise PLLA polymers that are naturally biodegradable. These stents have a polymer coating of poly-D,L-lactide, which enables the controlled release of various drugs.

By absorption rate, the market is sub-segmented into slow absorbable stents and fast absorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The slow rate of absorption enables the longer duration of drug release within the arteries. This ensures efficient healing. These factors may enable the market to witness significant growth in the future.

Based on application, the market is segmented into coronary artery disease and peripheral artery disease. In 2016, the coronary artery disease segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the factors such as increasing focus of companies towards developing bioabsorbable stents that can be used in coronary procedures and growing patient preference for minimally invasive surgical procedures.

Based on end user, the market is segmented into hospitals and cardiac centers. The hospital segment is expected to dominate the market and grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing patient pool and the rise in CAD and PAD prevalence, and initiatives and support programs to provide cost-effective and quality treatments to patients will enhance the affordability of a number of medical devices, including bioabsorbable stents.

Bioabsorbable Stents Market

The global bioabsorbable stents market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.

The bioabsorbable stents market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd.  (India) among others.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Minimally Invasive/Non-Invasive Surgery Markets on KnowledgeStore
Request Demo